Israeli Society of Medical Genetics NIPT committee opinion 072013: Non-invasive prenatal testing of cell-free DNA in maternal plasma for detection of fetal aneuploidy

Medicine and Dentistry

• Aneuploidy 100%
• Maternal Plasma 100%
• Cell-Free DNA 100%
• Health Care Cost 50%
• Counseling 50%
• Down Syndrome 50%
• Chromosome Aberration 50%
• Genetic Disorder 50%
• Consultation 50%
• Pregnancy 50%
• False Positive Result 50%
• Genetic Counseling 50%
• Prenatal Screening 50%
• Screening Test 50%
• Trisomy 21 50%
• Trisomy 18 50%
• Trisomy 13 50%
• Sex Chromosome Aberration 50%
• Cell-Free Fetal DNA 50%

Keyphrases

• Israeli Society 100%
• Medical Genetics 100%
• Maternal Plasma 100%
• Fetal Aneuploidy 100%
• Cell-free DNA (cfDNA) 100%
• Noninvasive Prenatal Testing 100%
• Abnormal Results 22%
• Medical Geneticist 22%
• Highly Sensitive 11%
• Patient Preference 11%
• Week of Gestation 11%
• High-risk Women 11%
• High Risk 11%
• Genetic Counseling 11%
• Clinical Data 11%
• Down Syndrome 11%
• Aneuploidy 11%
• Genetic Disease 11%
• Trisomy 21 11%
• Healthcare Professionals 11%
• Fetus 11%
• Genetic Consultation 11%
• Normal Test 11%
• False-positive Results 11%
• Prenatal Screening Tests 11%
• Sex Chromosome Aneuploidy 11%
• Invasive Prenatal Testing 11%
• Fetal Chromosomal Abnormalities 11%
• Trisomy 18 11%
• Trisomy 13 11%
• Informed Patient 11%
• Cell-free Fetal DNA 11%
• Fetal DNA in Maternal Plasma 11%
• Pretest Counseling 11%

Biochemistry, Genetics and Molecular Biology

• Medical Genetics 100%
• Aneuploidy 100%
• Genetics 50%
• Genetic Counseling 50%
• Down Syndrome 50%
• Trisomy 50%
• Genetic Disorder 50%
• Trisomy 21 50%
• Chromosomal Abnormalities 50%
• Pregnancy 50%
• Screening Test 50%
• Prenatal Screening 50%
• Sex Chromosome Aneuploidies 50%